Latest news
22-11-2024 - Innovations for Exceptionally Low-Cost Monoclonal Antibody (mAb) Manufacturing - New Grand Challenges Call Launched by Bill & Melinda Gates Foundation
The Bill & Melinda Gates Foundation (BMGF) Grand Challenge (GC) initiative seeks to engage innovators from around the world to solve the most pressing challenges in global health and development. This Innovations for Exceptionally Low-Cost Monoclonal Antibody (mAb) Manufacturing GC competition aims to source and seed innovations and accelerate the development of transformational solutions to reduce the cost of mAb production to a target of $10 per gram. For this call, BMGF is working in partnership with LifeArc, a UK-based medical research charity.
[...]